This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/chemspider/
n18http://linked.opendata.cz/resource/mesh/concept/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/chebi/
n16http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/kegg-compound/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/pubchem-compound/
n20http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/iuphar/
owlhttp://www.w3.org/2002/07/owl#
n17http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02998/identifier/guide-to-pharmacology/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02998
rdf:type
n3:Drug
n3:description
A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.
n3:group
experimental
owl:sameAs
n16:DB02998 n20:DB02998
dcterms:title
Methyltrienolone
adms:identifier
n6:229099 n7:DB02998 n8:379896 n9:C14257 n10:R18 n11:2857 n12:2857 n13:261000 n14:46505539
n3:synonym
17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one Metribolone
n17:hasConcept
n18:M0024129
n3:IUPAC-Name
n4:271B45A5-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B45AB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B45AA-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B45A7-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B45A8-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B45A9-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B45A3-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B45A1-363D-11E5-9242-09173F13E4C5 n4:271B45A4-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B45A2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B45B1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B45B2-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B45AC-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B45AD-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B45AF-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B45AE-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B45B0-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
965-93-5
n3:Bioavailability
n4:271B45B7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B45B9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B45BA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B45B6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B45B5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B45B8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B45A6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B45B3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B45B4-363D-11E5-9242-09173F13E4C5